The biology and clinical utility of EBV monitoring in blood

Jennifer Kanakry, Richard Ambinder

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Epstein-Barr virus (EBV) DNA in blood can be quantified in peripheral blood mononuclear cells, in circulating cell-free (CCF) DNA specimens, or in whole blood. CCF viral DNA may be actively released or extruded from viable cells, packaged in virions or passively shed from cells during apoptosis or necrosis. In infectious mononucleosis, viral DNA is detected in each of these kinds of specimens, although it is only transiently detected in CCF specimens. In nasopharyngeal carcinoma, CCF EBV DNA is an established tumor marker. In EBV-associated Hodgkin lymphoma and in EBV-associated extranodal NK-/T-cell lymphoma, there is growing evidence for the utility of CCF DNA as a tumor marker.

Original languageEnglish (US)
Title of host publicationCurrent Topics in Microbiology and Immunology
PublisherSpringer Verlag
Pages475-499
Number of pages25
DOIs
StatePublished - Oct 1 2015

Publication series

NameCurrent Topics in Microbiology and Immunology
Volume391
ISSN (Print)0070-217X
ISSN (Electronic)2196-9965

    Fingerprint

ASJC Scopus subject areas

  • Immunology and Allergy
  • Microbiology
  • Immunology
  • Microbiology (medical)

Cite this

Kanakry, J., & Ambinder, R. (2015). The biology and clinical utility of EBV monitoring in blood. In Current Topics in Microbiology and Immunology (pp. 475-499). (Current Topics in Microbiology and Immunology; Vol. 391). Springer Verlag. https://doi.org/10.1007/978-3-319-22834-1_17